Total Payments
$3,867
2024 Payments
$866.44
Companies
17
Transactions
154
Medicare Patients
60
Medicare Billing
$5,112
Payment Breakdown by Category
Food & Beverage$3,096 (80.1%)
Travel$604.15 (15.6%)
Education$166.60 (4.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,096 | 149 | 80.1% |
| Travel and Lodging | $604.15 | 1 | 15.6% |
| Education | $166.60 | 4 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neuronetics, Inc. | $1,426 | 16 | $0 (2024) |
| ABBVIE INC. | $599.88 | 34 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $496.47 | 29 | $0 (2024) |
| Alkermes, Inc. | $260.43 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $249.80 | 16 | $0 (2024) |
| ITI, Inc. | $224.96 | 11 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $174.46 | 7 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $126.49 | 9 | $0 (2022) |
| Allergan, Inc. | $82.66 | 4 | $0 (2020) |
| Supernus Pharmaceuticals, Inc. | $59.43 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $866.44 | 32 | Neuronetics, Inc. ($484.10) |
| 2023 | $627.52 | 35 | AbbVie Inc. ($207.90) |
| 2022 | $1,507 | 36 | Neuronetics, Inc. ($941.63) |
| 2021 | $203.88 | 13 | AbbVie Inc. ($45.36) |
| 2020 | $213.41 | 13 | Neurocrine Biosciences, Inc. ($84.13) |
| 2019 | $181.60 | 7 | Teva Pharmaceuticals USA, Inc. ($100.67) |
| 2018 | $144.93 | 9 | Sunovion Pharmaceuticals Inc. ($39.97) |
| 2017 | $121.93 | 9 | Otsuka America Pharmaceutical, Inc. ($68.61) |
All Payment Transactions
154 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Neurology | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.42 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: PSYCHIATRY | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Neuroscience | ||||||
| 08/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.75 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.46 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: PSYCHIATRY | ||||||
| 05/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: PSYCHIATRY | ||||||
| 05/06/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: CNS | ||||||
| 03/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: PSYCHIATRY | ||||||
| 02/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.81 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: PSYCHIATRY | ||||||
| 02/01/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $141.52 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 02/01/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $141.52 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 02/01/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $1.13 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 02/01/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $1.13 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 01/31/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $1.03 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 01/31/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $1.03 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 01/31/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $0.91 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 01/31/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $0.91 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 01/31/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $0.91 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 01/31/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $0.91 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 27 | 36 | $7,634 | $2,845 |
| 2020 | 2 | 33 | 59 | $10,453 | $2,267 |
Total Patients
60
Total Services
95
Medicare Billing
$5,112
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 11 | 11 | $3,427 | $1,497 | 43.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 16 | 25 | $4,208 | $1,348 | 32.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 12 | 38 | $6,027 | $2,006 | 33.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 21 | 21 | $4,426 | $261.35 | 5.9% |
About Dr. Mark Scanlan, MD
Dr. Mark Scanlan, MD is a Psychiatry healthcare provider based in Scottsbluff, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013933274.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Scanlan, MD has received a total of $3,867 in payments from pharmaceutical and medical device companies, with $866.44 received in 2024. These payments were reported across 154 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,096).
As a Medicare-enrolled provider, Scanlan has provided services to 60 Medicare beneficiaries, totaling 95 services with total Medicare billing of $5,112. Data is available for 2 years (2020–2021), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Scottsbluff, NE
- Active Since 07/14/2006
- Last Updated 11/15/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1013933274
Products in Payments
- NEUROSTAR TMS THERAPY SYSTEM (Device) $1,426
- VRAYLAR (Drug) $666.14
- REXULTI (Drug) $297.81
- CAPLYTA (Drug) $267.30
- INVEGA SUSTENNA (Drug) $249.80
- ARISTADA (Drug) $232.90
- ABILIFY MAINTENA (Drug) $175.76
- INGREZZA (Drug) $126.49
- AUSTEDO (Drug) $70.54
- QELBREE (Drug) $59.43
- LATUDA (Drug) $39.97
- Aristada 441 mg (Drug) $27.53
- ABILIFY ASIMTUFII (Drug) $22.90
- Auvelity (Drug) $20.35
- UZEDY (Drug) $17.43
- TRINTELLIX (Drug) $14.82
- NUPLAZID (Drug) $13.35
- Trintellix (Drug) $12.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.